Targeting nucleocytoplasmic transport in cancer therapy

The intracellular location and regulation of proteins within each cell is critically important and is typically deregulated in disease especially cancer. The clinical hypothesis for inhibiting the nucleo-cytoplasmic transport is based on the dependence of certain key proteins within malignant cells. This includes a host of well-characterized tumor suppressor and oncoproteins that require specifc localization for their function. This aberrant localization of tumour suppressors and oncoproteins results in their their respective inactivation or over-activation. This incorrect localization occurs actively via the nuclear pore complex that spans the nuclear envelope and is mediated by transport receptors. Accordingly, given the signifcant need for novel, specifc disease treatments, the nuclear envelope and the nuclear transport machinery have emerged as a rational therapeutic target in oncology to restore physiological nucleus/cytoplasmic homeostasis. Recent evidence suggests that this approach might be of substantial therapeutic use. This review summarizes the mechanisms of nucleo-cytoplasmic transport, its role in cancer biology and the therapeutic potential of targeting this critical cellular process

• Publication year

  2013

• Venue

  OncoTarget

• Publication date

  2013-11-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.18632/ONCOTARGET.1457PMID 24429466PMCID 3960186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Content Screening of Natural Products Reveals Novel Nuclear Export Inhibitors

  2014cited by this paper
• Moving to the Core: Spatiotemporal Analysis of Forkhead Box O (FOXO) and Nuclear Factor‐κB (NF‐κB) Nuclear Translocation

  2013cited by this paper
• Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models

  2013cited by this paper
• Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo

  2013cited by this paper
• Redox-dependent control of FOXO/DAF-16 by transportin-1.

  2013cited by this paper
• Targeting the nuclear transport machinery by rational drug design.

  2013cited by this paper
• Skipping cancer: small molecule inhibitors of SKP2-mediated p27 degradation.

  2012cited by this paper
• Nuclear export of proteins and drug resistance in cancer.

  2012influential reference
• Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions

  2012cited by this paper
• Direct and selective small-molecule activation of proapoptotic BAX.

  2012cited by this paper
• Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

  2012cited by this paper
• The Maintenance of Epigenetic States by p53: The Guardian of the Epigenome

  2012cited by this paper
• β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

  2012cited by this paper
• Regulation of p53: a collaboration between Mdm2 and MdmX

  2012cited by this paper
• Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response.

  2012cited by this paper
• Will PI3K pathway inhibitors be effective as single agents in patients with cancer?

  2011cited by this paper
• Nucleolar Targeting of the Fbw7 Ubiquitin Ligase by a Pseudosubstrate and Glycogen Synthase Kinase 3

  2011cited by this paper
• CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.

  2011cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• Importazole, a small molecule inhibitor of the transport receptor importin-β.

  2011cited by this paper
• Nuclear proteins acting on mitochondria.

  2011cited by this paper
• Exploiting p53 Status to Enhance Effectiveness of Chemotherapy by Lowering Associated Toxicity

  2011cited by this paper
• Protein localization in disease and therapy

  2011cited by this paper
• Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1

  2010cited by this paper
• Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-xL

  2010cited by this paper
• In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes

  2010cited by this paper
• High content screening: seeing is believing.

  2010cited by this paper
• BRCA1 16 years later: nuclear import and export processes

  2010influential reference
• Six new acylated anthocyanins from red radish (Raphanus sativus).

  2010cited by this paper
• The Anti-inflammatory Prostaglandin 15-Deoxy-Δ12,14-PGJ2 Inhibits CRM1-dependent Nuclear Protein Export*

  2010cited by this paper
• Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells

  2010cited by this paper
• Understanding FOXO, new views on old transcription factors.

  2010cited by this paper
• The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling

  2010cited by this paper
• Unprecedented NES non-antagonistic inhibitor for nuclear export of Rev from Sida cordifolia.

  2010cited by this paper
• Anguinomycins and derivatives: total syntheses, modeling, and biological evaluation of the inhibition of nucleocytoplasmic transport.

  2010cited by this paper
• Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport.

  2010cited by this paper
• The cytotoxic styryl lactone goniothalamin is an inhibitor of nucleocytoplasmic transport.

  2010cited by this paper
• The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

  2009cited by this paper
• New Rev-export inhibitor from Alpinia galanga and structure-activity relationship.

  2009cited by this paper
• Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators

  2009cited by this paper
• Identification of nuclear export inhibitors with potent anticancer activity in vivo.

  2009influential reference
• EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS

  2009cited by this paper
• NFAT proteins: emerging roles in cancer progression

  2009cited by this paper
• Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.

  2009cited by this paper
• The expression of CRM1 is associated with prognosis in human osteosarcoma.

  2009cited by this paper
• Awakening guardian angels: drugging the p53 pathway

  2009cited by this paper
• Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

  2009cited by this paper
• Therapeutic Targeting of Nuclear Protein Import in Pathological Cell Conditions

  2009cited by this paper
• Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases*

  2009cited by this paper
• Nuclear pore proteins and cancer.

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009influential reference
• Prognostic value of CRM1 in pancreas cancer.

  2009cited by this paper
• Chemical Genetic Analysis of FOXO Nuclear–Cytoplasmic Shuttling by Using Image‐Based Cell Screening

  2008influential reference
• Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

  2008cited by this paper
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cited by this paper
• A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling

  2008cited by this paper
• A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization

  2008cited by this paper
• Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.

  2008cited by this paper
• The nuclear affairs of PTEN

  2008cited by this paper
• FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells

  2008cited by this paper
• Cellular mechanisms of tumour suppression by the retinoblastoma gene

  2008cited by this paper
• Cohesin subunit SMC1 associates with mitotic microtubules at the spindle pole

  2008cited by this paper
• Involvement of FKHRL1 in melanoma cell survival and death

  2008cited by this paper
• The FoxO code

  2008cited by this paper
• Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling.

  2008cited by this paper
• Nucleolar protein B23 has molecular chaperone activities

  2008cited by this paper
• [In-vivo activation of the p53 pathway by small-molecule antagonists of MDM2].

  2007cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a (PII:S0092-8674(04)00302-2)

  2007cited by this paper
• Attenuated DNA Damage Repair by Trichostatin A through BRCA1 Suppression

  2007influential reference
• Nuclear Transport: Target for Therapy

  2007cited by this paper
• Nuclear export is essential for the tumor‐promoting activity of survivin

  2007cited by this paper
• High-Content Classification of Nucleocytoplasmic Import or Export Inhibitors

  2007influential reference
• The emerging roles of forkhead box (Fox) proteins in cancer

  2007cited by this paper
• The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members

  2007cited by this paper
• Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.

  2007cited by this paper
• Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions

  2007cited by this paper
• An HTS Approach to Screen for Antagonists of the Nuclear Export Machinery Using High Content Cell-Based Assays

  2007cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Separating the Anti-apoptotic and Mitotic Roles of Survivin*

  2006cited by this paper
• Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.

  2006cited by this paper
• A global map of p53 transcription-factor binding sites in the human genome.

  2006cited by this paper
• Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer

  2006cited by this paper
• Controlling Protein Compartmentalization to Overcome Disease

  2006cited by this paper
• Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity

  2005cited by this paper
• Nucleophosmin in acute myelogenous leukemia.

  2005cited by this paper
• RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

  2005cited by this paper
• Leucine-rich nuclear-export signals: born to be weak.

  2005cited by this paper
• Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1*

  2005cited by this paper
• Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes*

  2005cited by this paper
• Temporal and spatial control of nucleophosmin by the Ran–Crm1 complex in centrosome duplication

  2005cited by this paper
• Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

  2004cited by this paper
• IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

  2004cited by this paper
• Nuclear–cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1

  2004cited by this paper
• Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

  2004influential reference
• Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity

  2004influential reference
• Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer

  2004cited by this paper
• Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin.

  2004cited by this paper
• Nuclear transport and cancer: from mechanism to intervention

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper

• Structure‐Guided Synthetic Peptide Targeting Nucleolus and Neural Progenitor Protein Nuclear Import Impairs Ribosome Biogenesis and Cancer Cell Proliferation

  2026cites this paper
• Synthetic Integration of an FCS into Coronaviruses-Hype or an Unresolved Biorisk? An Integrative Analysis of DNA Repair, Cancer Research, Drug Development, and Escape Mutant Traits.

  2026cites this paper
• RSK Inhibition Rewires Kinase Networks and Triggers Cascading Pathway Disruption in Esophageal Cancer.

  2025cites this paper
• Investigating the Development of Colorectal Cancer Based on Spatial Transcriptomics

  2025cites this paper
• Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex

  2025cites this paper
• An evaluation of selinexor as a maintenance therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma

  2025cites this paper
• The Polybrominated Diphenyl Ether Bromoxib Disrupts Nuclear Import and Export by Affecting Nucleoporins of the Nuclear Pore Complex

  2025influential citation
• Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease

  2025cites this paper
• Synergistic activity of Pitstop-2 and 1,6-hexanediol in aggressive human lung cancer cells

  2025cites this paper
• Retroviral adapters hijack the RNA helicase UPF1 in a CRM1/XPO1-dependent manner and reveal proviral roles of UPF1

  2025cites this paper
• An Exploratory Bioinformatics Investigation of microRNA Signatures in Cisplatin- Resistant Gastric Cancer Cell Lines

  2025cites this paper
• Violaceoid F induces nuclear translocation of FOXO3a by inhibiting CRM1 via a novel mechanism and suppresses HeLa cell growth

  2024cites this paper
• The Potential of Nuclear Pore Complexes in Cancer Therapy

  2024cites this paper
• Thermal Stress and Nuclear Transport.

  2024cites this paper
• Statistical Testing for Protein Equivalence Identifies Core Functional Modules Conserved across 360 Cancer Cell Lines and Presents a General Approach to Investigating Biological Systems

  2024cites this paper
• Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer

  2024cites this paper
• Targeted Protein Relocalization via Protein Transport Coupling

  2023cites this paper
• Enlightening the path to NSCLC biomarkers: Utilizing the power of XAI-guided deep learning

  2023cites this paper
• Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy

  2023cites this paper
• Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma

  2023cites this paper
• Transcriptome sequencing and miRNA-mRNA network construction in exosome of macrophage M2 in stomach adenocarcinoma

  2023cites this paper
• LARP4A and LARP4B in cancer: The new kids on the block.

  2023cites this paper
• A general method for quantitative fractionation of mammalian cells

  2023cites this paper
• PLA-GNN: Computational inference of protein subcellular location alterations under drug treatments with deep graph neural networks

  2023cites this paper
• Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects

  2023cites this paper
• ahctf1 and kras mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma

  2023cites this paper
• Targeting XPO1-Dependent Nuclear Export in Cancer

  2022cites this paper
• Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells

  2022cites this paper
• Pitstop‐2 and its novel derivative RVD‐127 disrupt global cell dynamics and nuclear pores integrity by direct interaction with small GTPases

  2022cites this paper
• Nuclear interaction of Arp2/3 complex and BRAFV600E promotes aggressive behavior and vemurafenib resistance of thyroid cancer.

  2022cites this paper
• Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1‐mediated nuclear export

  2022cites this paper
• Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer

  2022cites this paper
• Subcellular fractionation of brain tumor stem cells.

  2022cites this paper
• Explainable artificial intelligence for precision medicine in acute myeloid leukemia

  2022cites this paper
• The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway

  2022cites this paper
• The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study

  2022cites this paper
• Simple and Efficient Protocol for Subcellular Fractionation of Normal and Apoptotic Cells

  2021cites this paper
• Novel Experimental Drugs for Treatment of Multiple Myeloma

  2021cites this paper
• New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking

  2021cites this paper
• Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP

  2021cites this paper
• Modulating undruggable targets to overcome cancer therapy resistance.

  2021cites this paper
• Impact of the Nuclear Envelope on Malignant Transformation, Motility, and Survival of Lung Cancer Cells

  2021cites this paper
• Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors

  2021cites this paper
• Elys deficiency constrains Kras-driven tumour burden by amplifying oncogenic stress

  2021cites this paper
• Novel small molecule inhibitor of Kpnβ1 induces cell cycle arrest and apoptosis in cancer cells.

  2021cites this paper
• Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma

  2021cites this paper
• Cellular rewiring in lethal prostate cancer: the architect of drug resistance

  2020cites this paper
• Modulating transcription factor activity: Interfering with protein-protein interaction networks.

  2020cites this paper
• Nucleus–cytoplasm cross‐talk in the aging brain

  2020cites this paper
• Selinexor for the treatment of multiple myeloma

  2020cites this paper
• Direct Cytosolic Delivery of Proteins Through Co-Engineering of Proteins and Polymeric Delivery Vehicles.

  2020cites this paper
• Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy

  2020cites this paper
• Small Molecule Inhibitors of CRM1

  2020cites this paper
• New drugs in early development for treating multiple myeloma: all that glitters is not gold

  2020cites this paper
• Characterization of inhibition reveals distinctive properties for human and Saccharomyces cerevisiae CRM1.

  2020cites this paper
• ZZW-115–dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents

  2020cites this paper
• The hippo kinase STK38 ensures functionality of XPO1

  2020cites this paper
• The STK38–XPO1 axis, a new actor in physiology and cancer

  2020cites this paper
• Inducible nuclear import by TetR aptamer-controlled 3′ splice site selection

  2020cites this paper
• Differential expression of Ran-binding protein 2 (RanBP2) and Targeting Protein for Xklp2 (TPX2) in head and neck squamous cell carcinoma cells

  2020cites this paper
• PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression

  2019cites this paper
• Tandem mass tag-based quantitative proteomic analysis of lycorine treatment in highly pathogenic avian influenza H5N1 virus infection

  2019cites this paper
• Dynamische Kopplung bei niedriger Reynoldszahl

  2019cites this paper
• Differential expression and molecular interactions of chromosome region maintenance 1 and calreticulin exportins in breast cancer cells.

  2019cites this paper
• FOXO Transcription Factors: Methods and Protocols

  2019cites this paper
• Dynamic Coupling at Low Reynolds Number.

  2019cites this paper
• Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability

  2019cites this paper
• Characterising the anticancer effects of a small molecule with potential to inhibit nuclear import via karyopherin beta1

  2018influential citation
• Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way

  2018cites this paper
• Analysis of Gene Expression Data of RPL10 Mutant T-Cell Leukemia by SEMsubPA

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer

  2018cites this paper
• High-Throughput Image-Based Screening to Identify Chemical Compounds Capable of Activating FOXO.

  2018cites this paper
• Image-based Identification of Chemical Compounds Capable of Trapping FOXO in the Cell Nucleus.

  2018cites this paper
• Targeting Nucleoporin POM121-Importin β Axis in Prostate Cancer.

  2018cites this paper
• Prognostic Role of BRAFV600E Cellular Localization in Melanoma.

  2018cites this paper
• Quantitation of IRF3 Nuclear Translocation in Heterogeneous Cellular Populations from Cervical Tissue Using Imaging Flow Cytometry.

  2018cites this paper
• Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL

  2018cites this paper
• Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor

  2018cites this paper
• Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction

  2018cites this paper
• Integrated analysis of gene expression signatures associated with colon cancer from three datasets.

  2018cites this paper
• Clinical Implications of Targeting XPO1‐mediated Nuclear Export in Multiple Myeloma

  2018cites this paper
• Regulation of Nucleocytoplasmic Shuttling of the Transcriptional Regulator Human Mesoderm Induction Early Response 1 α in Breast Carcinoma Cells

  2018cites this paper
• Computational identification of phosphorylation sites around nuclear localization signal sequence reveals new insight into genes associated with human diseases

  2017cites this paper
• Dietary Flavonoids, CYP1A1 Genetic Variants, and the Risk of Colorectal Cancer in a Korean population

  2017cites this paper
• 5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner

  2017cites this paper
• Aberrant expression of karyopherin α2 ( KPNA 2 ) contributes to poor prognosis of non-small cell lung cancer

  2017cites this paper
• Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs.

  2017cites this paper
• Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach

  2017cites this paper
• CRM1 inhibitory and antiproliferative activities of novel 4'-alkyl substituted klavuzon derivatives.

  2017cites this paper
• A Carbon Nanotube Optical Sensor Reports Nuclear Entry via a Noncanonical Pathway.

  2017cites this paper
• Reverse the Resistance to PARP Inhibitors

  2017cites this paper
• O-GlcNAc cycling and the regulation of nucleocytoplasmic dynamics.

  2017cites this paper
• The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas

  2016cites this paper
• Inside out: the role of nucleocytoplasmic transport in ALS and FTLD

  2016cites this paper
• Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC)

  2016cites this paper
• Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation

  2016cites this paper
• Drug Repurposing to Circumvent Chemotherapy Resistance in Brain Tumours

  2016cites this paper
• Subcellular Protein Localisation in Health and Disease

  2016cites this paper
• Colorectal cancer risk genes are functionally enriched in regulatory pathways

  2016cites this paper